Profile data is unavailable for this security.
About the company
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
- Revenue in USD (TTM)4.09bn
- Net income in USD374.90m
- Incorporated1980
- Employees15.00k
- LocationCooper Companies Inc6101 Bollinger Canyon Road, Suite 500SAN RAMON 94583United StatesUSA
- Phone+1 (925) 460-3600
- Fax+1 (510) 460-3649
- Websitehttps://www.coopercos.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Henry Schein Inc | 12.94bn | 391.00m | 9.06bn | 25.00k | 24.33 | 2.72 | 12.84 | 0.7006 | 3.17 | 3.17 | 104.73 | 28.35 | 1.19 | 4.86 | 7.60 | 517,520.00 | 3.70 | 5.43 | 6.36 | 9.19 | 31.19 | 30.23 | 3.10 | 3.98 | 0.7885 | 6.59 | 0.3872 | 0.00 | 2.71 | 4.88 | -6.25 | -11.06 | 19.66 | -- |
| Baxter International Inc | 11.02bn | -355.00m | 11.19bn | 38.00k | -- | 1.55 | 17.68 | 1.02 | -0.6925 | -0.6654 | 21.46 | 14.09 | 0.4618 | 3.14 | 6.08 | 290,078.90 | -1.48 | -0.8441 | -1.87 | -1.03 | 35.05 | 38.63 | -3.20 | -2.03 | 1.18 | 3.42 | 0.5684 | -- | 2.66 | -1.31 | -293.68 | -- | -8.52 | 1.60 |
| Revvity Inc | 2.86bn | 239.88m | 11.28bn | 11.00k | 48.05 | 1.56 | 17.49 | 3.95 | 2.07 | 2.08 | 24.49 | 63.95 | 0.2326 | 3.46 | 4.15 | -- | 1.95 | 3.23 | 2.13 | 3.58 | 54.77 | 58.48 | 8.40 | 13.58 | 1.40 | 5.23 | 0.3075 | 8.52 | 3.67 | -5.47 | -15.26 | -19.91 | -1.05 | 0.00 |
| Globus Medical Inc | 2.77bn | 423.78m | 11.71bn | 5.30k | 28.28 | 2.68 | 16.73 | 4.23 | 3.09 | 3.09 | 20.09 | 32.68 | 0.5441 | 1.29 | 4.59 | 522,604.50 | 8.32 | 4.70 | 9.53 | 5.18 | 65.34 | 66.40 | 15.30 | 9.73 | 2.47 | 15.96 | 0.0002 | 0.00 | 60.62 | 26.25 | -16.19 | -7.88 | 10.29 | -- |
| Align Technology Inc | 4.03bn | 410.35m | 12.60bn | 20.95k | 31.04 | 3.11 | 30.73 | 3.12 | 5.66 | 5.66 | 55.58 | 56.43 | 0.6483 | 5.33 | 3.85 | -- | 6.59 | 8.11 | 9.67 | 11.97 | 68.25 | 70.40 | 10.17 | 12.31 | 1.24 | -- | -- | -- | 0.899 | 10.30 | -2.61 | -25.40 | -- | -- |
| Guardant Health Inc | 902.57m | -398.79m | 12.67bn | 2.00k | -- | -- | -- | 14.04 | -3.21 | -3.21 | 7.27 | -2.84 | 0.6411 | 4.02 | 8.85 | 451,510.30 | -28.33 | -24.20 | -33.49 | -26.83 | 63.76 | 63.23 | -44.18 | -91.24 | 3.12 | -10.70 | 1.47 | -- | 31.04 | 28.08 | 8.98 | -- | 10.58 | -- |
| Solventum Corp | 8.40bn | 1.52bn | 13.35bn | 22.00k | 8.86 | 2.68 | 6.53 | 1.59 | 8.69 | 8.69 | 48.01 | 28.75 | 0.5851 | 3.85 | 7.91 | 381,909.10 | 10.61 | -- | 13.32 | -- | 54.18 | -- | 18.13 | -- | 1.14 | 1.76 | 0.5075 | -- | 0.6954 | -- | -64.41 | -- | -- | -- |
| Penumbra Inc | 1.33bn | 164.03m | 13.42bn | 4.50k | 82.53 | 9.85 | 73.95 | 10.06 | 4.14 | 4.14 | 33.63 | 34.70 | 0.8276 | 1.07 | 7.42 | 296,399.60 | 10.18 | 1.42 | 11.31 | 1.58 | 66.80 | 63.21 | 12.30 | 1.96 | 4.18 | -- | 0.0171 | 0.00 | 12.86 | 16.89 | -84.59 | -21.98 | -0.853 | -- |
| Cooper Companies Inc | 4.09bn | 374.90m | 15.70bn | 15.00k | 42.75 | 1.90 | 20.87 | 3.84 | 1.87 | 1.87 | 20.46 | 42.06 | 0.3312 | 1.71 | 5.29 | 272,826.70 | 3.03 | 8.04 | 3.32 | 8.86 | 65.54 | 66.01 | 9.16 | 24.66 | 1.13 | 6.32 | 0.2332 | 0.2049 | 5.06 | 10.98 | -4.44 | 9.48 | 3.15 | -- |
| West Pharmaceutical Services Inc | 3.02bn | 491.70m | 16.66bn | 10.60k | 34.32 | 5.46 | 25.86 | 5.52 | 6.75 | 6.75 | 41.41 | 42.44 | 0.7757 | 4.63 | 5.13 | 284,707.60 | 12.32 | 15.61 | 14.46 | 18.70 | 35.58 | 38.00 | 15.88 | 18.84 | 2.18 | -- | 0.0638 | 10.20 | -1.92 | 9.48 | -16.97 | 15.31 | 24.43 | 5.84 |
| Hologic Inc | 4.13bn | 543.80m | 16.68bn | 7.07k | 31.00 | 3.18 | 19.87 | 4.04 | 2.41 | 2.41 | 18.28 | 23.51 | 0.4608 | 2.57 | 6.79 | 583,663.40 | 6.07 | 11.22 | 6.82 | 12.85 | 56.51 | 60.20 | 13.18 | 21.99 | 3.32 | 15.76 | 0.3246 | 0.00 | 1.74 | 1.66 | -28.35 | -12.69 | -0.5168 | -- |
| Insulet Corp | 2.52bn | 246.20m | 17.10bn | 3.90k | 70.55 | 12.36 | 51.26 | 6.78 | 3.45 | 3.45 | 34.85 | 19.68 | 0.833 | 1.62 | 6.02 | 646,641.00 | 8.13 | 6.00 | 10.05 | 7.03 | 71.46 | 67.05 | 9.76 | 9.22 | 2.18 | 27.39 | 0.423 | 0.00 | 22.07 | 22.92 | 102.76 | 104.84 | -4.75 | -- |
| Zimmer Biomet Holdings Inc | 8.01bn | 805.20m | 17.58bn | 17.00k | 21.96 | 1.38 | 9.35 | 2.20 | 4.04 | 4.04 | 40.22 | 64.36 | 0.3544 | 0.943 | 5.20 | 471,235.30 | 3.57 | 2.34 | 4.12 | 2.68 | 71.44 | 71.18 | 10.08 | 7.60 | 1.39 | 5.41 | 0.3886 | 37.52 | 3.85 | -0.7725 | -11.74 | 2.05 | -3.69 | 0.00 |
| Illumina Inc | 4.34bn | 850.00m | 20.42bn | 8.97k | 24.45 | 7.50 | 28.36 | 4.70 | 5.46 | 5.46 | 27.84 | 17.82 | 0.6709 | 2.61 | 5.41 | -- | 13.13 | -10.15 | 17.32 | -12.15 | 66.61 | 65.39 | 19.57 | -23.18 | 1.72 | -- | 0.4221 | -- | -0.6633 | 6.04 | 169.50 | 5.32 | -- | -- |
Data as of Feb 06 2026. Currency figures normalised to Cooper Companies Inc's reporting currency: US Dollar USD
43.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 21.59m | 11.02% |
| Capital Research & Management Co. (World Investors)as of 30 Sep 2025 | 10.55m | 5.38% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 9.84m | 5.02% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2025 | 9.83m | 5.01% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 8.59m | 4.38% |
| Kayne Anderson Rudnick Investment Management LLCas of 30 Sep 2025 | 7.55m | 3.85% |
| Geode Capital Management LLCas of 30 Sep 2025 | 5.30m | 2.71% |
| Wellington Management Co. LLPas of 30 Sep 2025 | 4.87m | 2.48% |
| Sustainable Growth Advisers LPas of 30 Sep 2025 | 4.13m | 2.11% |
| Neuberger Berman Investment Advisers LLCas of 30 Sep 2025 | 3.88m | 1.98% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
